Biopharma SPAC Jiya Acquisition priced its $100M IPO. The company intends to start trading today on the Nasdaq under the symbol “JYAC”. The company in earlier filings has said it may raise up to $25 million more at the closing of any merger under terms of a forward purchase agreement. Notice of effectiveness.
Related Posts
Verity Acquisition Withdraws $175M IPO
The SPAC had planned to pursue prospective targets based in the United States in the healthcare sector with an enterprise value of between $400 million and $1 billion.
Swiftmerge Acquisition Files $250M IPO
The SPAC intends to target businesses in the "innovative consumer" space -- companies using technology and the Internet to evolve the way consumers interact with the marketplace.
Kensington II Adds $11M PIPE to Support Wallbox Deal
Redemptions ahead of the shareholder meeting pulled the SPAC's cash in trust below the minimum required to close the deal, although Wallbox had agreed to waive the requirement. With the new PIPE the SPAC now exeeds the $250 million minimum cash condition.
Fintech Ecosystem Development Prices $100M IPO
The SPAC intends to pursue prospective targets in South Asia with particular emphasis on the financial technology industry.